Skip to main content

Table 3 Study II echocardiography

From: Systemic and cardiac susceptibility of immune compromised mice to doxorubicin

   5 weeks
BASELINE DOXORUBICIN
Parameter Unit MEAN SE MEAN SE
LVAW;d mm 0.88 0.08 0.70 0.09
LVAWS;s mm 1.25 0.11 0.80* 0.04
LVID;d mm 3.88 0.14 3.39 0.28
LVID;s mm 2.62 0.21 2.61 0.27
LVPW;d mm 0.89 0.03 0.79 0.08
LVPW;s mm 1.17 0.06 0.89* 0.04
Cardiac Output ml/min 20.44 2.46 10.77* 3.12
Ejection Fraction % 62.50 5.03 49.80* 7.57
Fractional Shortening % 33.60 3.43 25.20* 4.66
Heart Rate BPM 488 17 400 49
Stroke Volume μl 41.52 3.80 24.84* 5.53
Volume;d μl 67.51 6.79 49.78 9.86
Volume;s μl 26.00 5.35 24.94 6.24
  N = 3 m, 2f N = 3 m, 2f
  1. LV left ventricle, AW anterior wall, ID internal diameter, PW posterior wall, d diastolic, s systolic, BPM beats per minute. *p < 0.05, paired t-test